Skip to main content

All Miami Cancer Institute

Submissions from 2017 2017

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525, Minesh Mehta

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529, Andre Abitbol

Advance Care Planning: A Window to Palliative Care, Suleyki Medina

The Collaborative Support Model: A Unique Process to On-board Oncology Infusion Nurses, Diane Kramer, Kayce Tugg, Alice Cockerel, and Charlene Mears

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, Minesh Mehta

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Minesh Mehta

Concurrent diagnosis of glioblastoma (GBM), neuromyelitis optica (NMO) spectrum disorder and Progressive Multifocal Leukoencephalopathy (PML): imaging, pathology, and clinical course. (P5.161), Yazmin Odia

BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors, Ashley Roque and Yazmin Odia

Integrative Oncology: A Paradigm Shift, Yoon-Hang "John" Kim

Performance of a Web-based Method for Generating Synoptic Reports, Mercy Mena-Allauca, Patricia Carrion, Xiaorong Mei, Arniris Narciandi, Edwin Gould, and Andrew Renshaw

Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta

Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients, Minesh Mehta

Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles, Suresh Rana

Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials, Minesh Mehta

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta

Florida Pharmacy Students’ Perspectives on Careers in Oncology, Joseph Ladd

Radiation Therapy for Liver Tumors: The State-of-the-art, Miguel Perez and Michael Chuong

Submissions from 2016 2016

Reporting Gleason grade/score in synoptic reports of radical prostatectomies, Andrew Renshaw, Mercy Mena-Allauca, and Edwin Gould

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial, Miguel Villalona Calero

Reply to M.C. Chamberlain, Minesh Mehta

Emergency Nurse Transport of Telemetry Patients: Benefits and Drawbacks, Marcia Schram, Andrea Prentiss, Eve Butler, Joy Cerilo Delgado, Ann Marie D'Elia, Vivian Fuentes, Teresa Mancuso, Yvette Naranjo, Brenda Rojas, Martha Tijerino, Michelle Thomas, and Christine Williams

Married State Preceptorship Model: Crossing the State Line in New Graduate Nurse Transition to Practice, Solimar Figueroa, Jose Irizarry, and Tanya Cohn

Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study, Minesh Mehta

Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely ® Initiative, Starr Mautner